Home / Remifentanil / Norway
NO ATC N01AH06 · updated 2 Nov 2026
Remifentanil shortage in Norway
Is there a Remifentanil shortage in Norway?
Yes. As of 2 Nov 2026, 1 Remifentanil product is reported short in Norway, the first since 1 Mar 2026. The company estimate for the return is 31 Dec 2026. Main reason: commercial decision or withdrawal.
Also short in United States, Canada, Czechia, Australia. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Ultiva 1 mg pulver til injeksjons-/infusjonsvæske, oppløsning, 5x1 mg hetteglass | Aspen Pharma Trading Limited | 1 Mar 2026 | 31 Dec 2026 | Commercial decision or withdrawal Kommersielle grunner |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).